- Home
- RRR vs LGND Comparison
RRR vs LGND Comparison
Compare RRR & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RRR
- LGND
- Stock Information
- Founded
- RRR 1976
- LGND 1987
- Country
- RRR United States
- LGND United States
- Employees
- RRR N/A
- LGND 68
- Industry
- RRR Hotels/Resorts
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- RRR Consumer Discretionary
- LGND Health Care
- Exchange
- RRR Nasdaq
- LGND Nasdaq
- Market Cap
- RRR 3.7B
- LGND 3.2B
- IPO Year
- RRR 2016
- LGND 1992
- Fundamental
- Price
- RRR $61.10
- LGND $165.23
- Analyst Decision
- RRR Buy
- LGND Strong Buy
- Analyst Count
- RRR 12
- LGND 8
- Target Price
- RRR $60.17
- LGND $144.71
- AVG Volume (30 Days)
- RRR 688.6K
- LGND 139.7K
- Earning Date
- RRR 11-06-2025
- LGND 08-05-2025
- Dividend Yield
- RRR 3.24%
- LGND N/A
- EPS Growth
- RRR 3.75
- LGND N/A
- EPS
- RRR 2.94
- LGND N/A
- Revenue
- RRR $1,987,845,000.00
- LGND $181,488,000.00
- Revenue This Year
- RRR $4.18
- LGND $18.41
- Revenue Next Year
- RRR $3.42
- LGND $18.87
- P/E Ratio
- RRR $20.98
- LGND N/A
- Revenue Growth
- RRR 7.47
- LGND 53.40
- 52 Week Low
- RRR $35.09
- LGND $81.74
- 52 Week High
- RRR $63.60
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- RRR 54.88
- LGND 67.82
- Support Level
- RRR $60.50
- LGND $162.74
- Resistance Level
- RRR $61.92
- LGND $169.00
- Average True Range (ATR)
- RRR 1.24
- LGND 3.31
- MACD
- RRR -0.31
- LGND -0.70
- Stochastic Oscillator
- RRR 25.91
- LGND 64.20
About RRR Red Rock Resorts Inc.
Red Rock Resorts Inc along with its subsidiary is a gaming, development and management company that develops and operates strategically-located casino and entertainment properties. Its casino properties are conveniently located throughout the Las Vegas valley and provide its customers a wide variety of entertainment and dining options. The majority of revenue is derived from Casinos.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.